/Companies

Bioptamers

1 known investors

Find your way into Bioptamers

Sign up to see every warm intro you have to Bioptamers

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioptamers team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Bioptamers develops personalized precision cancer therapies that identify targetable molecular signatures unique to each patient's tumor and deliver therapeutics directly to cancer cells. Its target-agnostic platform aims to treat primary tumors and metastatic disease while reducing off-target effects.

Investors · 1

Frequently asked questions

What does Bioptamers do?
Bioptamers develops personalized precision cancer therapies that identify targetable molecular signatures unique to each patient's tumor and deliver therapeutics directly to cancer cells. Its target-agnostic platform aims to treat primary tumors and metastatic disease while reducing off-target effects.
Who are Bioptamers's investors?
Bioptamers's investors include SOSV.